Bright Minds Biosciences Inc (DRUG) Stock Analysis

Bright Minds Biosciences Inc (DRUG) is a publicly traded company in the HEALTHCARE sector. It trades at $76.78, carries a market capitalization of $850.71M. This page summarizes the public market data, fundamentals, and frequently asked questions for DRUG, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $76.78
• Market Cap: $850.71M
• EPS: $-2.47
• 52-Week High: $123.75
• 52-Week Low: $23.18

Market Sentiment

Bright Minds Biosciences Inc currently has a Bullish sentiment score of 0.35.

About Bright Minds Biosciences Inc

None

GNG Research Analysis

GNG Research scores Bright Minds Biosciences Inc (DRUG) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DRUG.

Frequently Asked Questions

Does DRUG pay dividends?

Bright Minds Biosciences Inc (DRUG) does not currently pay a regular dividend.

What is DRUG's market cap?

Bright Minds Biosciences Inc (DRUG) has a market capitalization of $850.71M with a current stock price of $76.78.